Duration of Anti-PD-1 Therapy in Metastatic Melanoma
Duration of Anti-PD-1 Therapy in Metastatic Melanoma
Recruiting · NCT02821013 · Registry updated 2026-06-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Duration of Anti-PD-1 Therapy in Metastatic Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 3 | 2026-06-09 | NCT02821013 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Cancer Trials Group | 73 |
| Melanoma and Skin Cancer Trials Limited | 10 |
30 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.